Loading companies…
Loading companies…
United States · Biotech
Develops inhaled therapies for severe respiratory diseases
| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series B | $103M | 5AM Ventures — Role not disclosedAtlas Venture — Role not disclosedEQT Life Sciences — Role not disclosedForge Life Science Partners — Role not disclosedGimv — Role not disclosedPictet Alternative Advisors — Role not disclosedRA Capital Management — Role not disclosedSchroders Capital — Role not disclosedSixty Degree Capital — Role not disclosedVivo Capital — Role not disclosedWillett Advisors — Role not disclosed |